Clearbridge Health (SGX:1H3) Cash-to-Debt : 0.59 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Clearbridge Health's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.59.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Clearbridge Health couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Clearbridge Health's Cash-to-Debt or its related term are showing as below:

SGX:1H3' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.58 Med: 1.96 Max: No Debt
Current: 0.59

During the past 10 years, Clearbridge Health's highest Cash to Debt Ratio was No Debt. The lowest was 0.58. And the median was 1.96.

SGX:1H3's Cash-to-Debt is ranked worse than
63.16% of 228 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.285 vs SGX:1H3: 0.59

Clearbridge Health Cash-to-Debt Historical Data

The historical data trend for Clearbridge Health's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Clearbridge Health Cash-to-Debt Chart

Clearbridge Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.58

0.69

1.14

0.81

0.59

Clearbridge Health Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial													1.14	1.22	0.81	0.51	0.59

Competitive Comparison of Clearbridge Health's Cash-to-Debt

For the Diagnostics & Research subindustry, Clearbridge Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearbridge Health's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Clearbridge Health's Cash-to-Debt falls into.

Clearbridge Health Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Clearbridge Health's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4.484	/	(2.037	+	5.599)
	=	0.59

Clearbridge Health's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4.484	/	(2.037	+	5.599)
	=	0.59

Clearbridge Health (SGX:1H3) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Clearbridge Health Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearbridge Health (SGX:1H3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177

Website

https://www.clearbridgehealth.com

Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (SGX:1H3) Headlines

No Headlines